Hypertension and hepatic steatosis

descriptionPublicationkeyboard_double_arrow_right Article 01 Jun 2008 English Publisher:Springer Science and Business Media LLCJournal:Current Hypertension Reports, volume 10, pages 182-187 (issn: 1522-6417, eissn: 1534-3111,

Copyright policy )

Authors: Matthew J, Brookes; Tariq H, Iqbal; Brian T, Cooper;

doi: 10.1007/s11906-008-0035-9

pmid: 18765087

Hypertension and hepatic steatosis

- Summary
- Subjects
- Metrics

Abstract

Hepatic steatosis (fatty liver) is increasingly recognized as a major component of the metabolic (insulin resistance) syndrome. It can progress to cirrhosis and hepatocellular carcinoma, leading to liver-related mortality. Increasing evidence shows a significant association between hepatic steatosis and hypertension; both are linked to the metabolic syndrome. This review discusses the evidence to support this association, and reviews the diagnosis and management of hepatic steatosis.

Related Organizations

City Hospital
United Kingdom

Keywords

Fatty Liver, Metabolic Syndrome, Risk Factors, Hypertension, Disease Progression, Humans, Hypoglycemic Agents, Insulin Resistance

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	3
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average